Penicillin

views updated

PENICILLIN.

BIBLIOGRAPHY

In the second half of the twentieth century penicillin was the best known of a new class of drugs—antibiotics—that revolutionized the treatment of communicable diseases and allowed doctors to rapidly cure a large number of bacterial infections. Beyond its role as a specific therapy, penicillin, often referred to as the "Wonder Drug," initiated a transformation in the pharmaceutical industry and was the principal symbol of medical progress for a generation.

The word penicillin was coined by the Scots scientist Alexander Fleming (1881–1955) in 1929 for the substance produced by the mold Penicillium that he found to be active against certain disease-causing bacteria. Fleming, like other before him, notably C. G. Paine (1905–?) in Sheffield, England, tried to use the substance therapeutically but had little success and did not pursue the possibility. However, its potential was explored again in the late 1930s by Howard Florey (1898–1968) and Ernst Chain (1906–1979) at Oxford, who were researching naturally occurring antibacterial substances. With the help of Norman Heatley (1911–2004), they improved the purity and hence the activity of extracts from the mold. Penicillin was first tested successfully on mice in the May 1940.

The Oxford group treated their first patient on 12 February 1941, a policeman who was close to death due to an infection. His condition improved while he was being administered penicillin, but he died when supplies ran out. However, other successful cases followed and from the summer of 1941 the Oxford group began working with British companies to develop large-scale production. At this point in World War II, with British industry stretched and suffering regular bombing raids, such opportunities were limited, so Florey approached the United States government for assistance in production. He was referred to the U.S. Department of Agriculture and in turn to the Northern Regional Research Laboratory at Peoria, Illinois. Scientists there had the necessary expertise in fungal fermentation and introduced a number of crucial process innovations that enabled high-volume, high-quality production of pure penicillin. This enabled further clinical trials, all of which showed that penicillin had great advantages over the limited number of existing antibacterial drugs, being less toxic and curing a wider range of infections.

Penicillin was soon being trumpeted as a major boon to the war effort, helping save the lives of combatants and civilians, especially those with wound infections and burns, and as yet another example of the contribution of science to social progress. In 1943 the U.S. government increased the priority given to penicillin, so by the end of the war it was being produced by many companies across the United States and to a lesser extent in Britain. Fleming became something of a celebrity and for a while the role played by Florey, Chain, Heatley, and the Peoria scientists who were all still actively at work on penicillin was eclipsed; however, in 1945 Florey, Chain, and Fleming were jointly awarded the Nobel Prize for Medicine.

In the late 1940s and early 1950s penicillin continued to enjoy a reputation as the "Wonder Drug," with demand outstripping supply. Penicillin had a major impact in saving lives and reducing suffering, and it transformed the image of the doctor from someone who helped patients manage their illnesses to someone who could cure disease. It also reduced the length of stay of surgical and infectious disease patients in hospitals, as secondary infections could be better controlled, although its use in general practice was limited by the fact that administration was by injection. While penicillin enjoyed an almost wholly positive public image, doctors and pharmaceutical companies were aware of two problems: first, penicillin-resistant bacteria, and, second, allergic reactions to the drug. The former had been known about since 1942, but the numbers of bacteria with this property increased with the rapid diffusion of penicillin and were common in hospitals in the 1950s. This led doctors to return to more traditional antiseptic and aseptic techniques and to look to new antibiotics being produced by the pharmaceutical industry. Allergies to penicillin can cause death and were more common in the 1950s, when high doses were used, than they are in the early twenty-first century. Although deaths were relatively rare, they often received wide publicity and, along with greater awareness of bacterial resistance, led to growing anxieties that penicillin might not be that wonderful after all. On balance, public confidence in the drug was not dented, as it was the experience of both patients and doctors that the benefits easily outweighed the risks. Indeed, it seems that penicillin was overused, with many doctors prescribing it for all infections, including viral infections (against which it is ineffective), on the grounds that it might prevent secondary bacterial infections. Another factor is that doctors were under pressure from patients who were unaware of the limitations and problems of the "Wonder Drug."

In the postwar period the huge market for penicillin and the problems with bacterial resistance led pharmaceutical companies to search for other naturally occurring antibiotics. The most important of these was streptomycin, introduced in 1946 as a treatment for tuberculosis, the most serious bacterial infection against which penicillin was ineffective. Scientists also found new penicillins produced by the various species of the Penicillium mold. Research in the 1950s concentrated on refining dosage recommendations and improving methods of administration—the first oral penicillins were introduced in 1954. In the late 1950s, research and development focused on semisynthetic and synthetic penicillins, with scientists offering improvements in administration and effectiveness. The range of new penicillins enabled doctors to keep ahead of bacterial resistance to antibiotics, but this has proved something of a treadmill and over time other drugs have replaced penicillins in the fight against resistant bacteria. However, for many common bacterial infections penicillin-based antibiotics remain the drug of choice at the start of the twenty-first century and continue to be a potent symbol of medical advance.

See alsoPublic Health; Science.

BIBLIOGRAPHY

Masters, David. Miracle Drug: The Inner History of Penicillin. London, 1946. The first detailed account of the development of penicillin.

Wainwright, Milton. Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics. Oxford, U.K., 1990. A detailed study of the development of penicillin and the issues around its development.

Weatherall, Miles. In Search of a Cure: A History of Pharmaceutical Discovery. Oxford, U.K., 1990. Places the history of penicillin in the context of wider developments in pharmaceuticals.

Michael Worboys

More From encyclopedia.com